title: [Oral, low-dosage methotrexate in chronic progressive multiple sclerosis. A preliminary critical analysis].
authors.affiliation: Neurologische Klinik und Poliklinik, Universität, Würzburg.
authors.forename: F X
authors.initials: FX
authors.lastname: Weilbach
authors.forename: K V
authors.initials: KV
authors.lastname: Toyka
authors.forename: H P
authors.initials: HP
authors.lastname: Hartung
mesh_terms: D000328:Adult; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy*; D009460:Neurologic Examination / Q000187:drug effects; D011446:Prospective Studies
chemical_list: D007166:Immunosuppressive Agents; D008727:Methotrexate
vernacular_title: Orales, niedrig dosiertes Methotrexat bei chronisch-progredienter multipler Sklerose. Eine vorläufige kritische Analyse.